source
- Caspian Therapeutics launches with $50M funding and Eli Lilly backing to develop menin inhibitor for diabetesCaspian Therapeutics has been created as a spin-out from Kura Oncology to advance a menin-targeting drug for diabetes. The company received $50 million in initial capital, led by BVF Partners with…
- Biopharma looks beyond China to five alternative overseas markets amid rising geopolitical tensionsGeopolitical tensions between the United States and China are prompting biopharma companies to look beyond the Chinese market for growth. China remains the leading destination, with licensing deal…